Immunochemical Analysis of Vesicular Monoamine Transporter (VMAT2) Protein in Parkinson's Disease
- 1 March 1999
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 156 (1) , 138-148
- https://doi.org/10.1006/exnr.1998.7008
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Vesicular Transport Regulates Monoamine Storage and Release but Is Not Essential for Amphetamine ActionNeuron, 1997
- Presynaptic monoaminergic vesicles in Parkinson's disease and normal agingAnnals of Neurology, 1996
- Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter.Proceedings of the National Academy of Sciences, 1996
- The dopamine transporter: immunochemical characterization and localization in brainJournal of Neuroscience, 1995
- Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalonMolecular Brain Research, 1994
- Functional Identification and Molecular Cloning of a Human Brain Vesicle Monoamine TransporterJournal of Neurochemistry, 1993
- Neural degeneration and the transport of neurotransmittersAnnals of Neurology, 1993
- In vivo imaging of monoaminergic nerve terminals in normal and MPTP‐lesioned primate brain using positron emission tomography (PET) and [11C]tetrabenazineSynapse, 1993
- Expression cloning of a reserpine-sensitive vesicular monoamine transporter.Proceedings of the National Academy of Sciences, 1992